Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Guarnieri

Fabio Ariel Guarnieri, Entre Rios AR

Patent application numberDescriptionPublished
20100042209IMPLANTABLE OCULAR MICROAPPARATUS TO AMELIORATE GLAUCOMA OR AN OCULAR OVERPRESSURE CAUSING DISEASE - A microapparatus (02-18-2010

Frank Guarnieri, Brooklyn, NY US

Patent application numberDescriptionPublished
20100284969Methods and Compositions for Delivery of Medicaments to the Lungs - The disclosure provides a drug composition formulated for inhalation comprising a conjugate of a surface active agent and a pulmonary active drug. The surface active agent has an affinity for the human alveolar/gas interface and comprises at least a portion of a mammalian lung surfactant of a mimic thereof. The disclosure also provides a method of treating a subject suffering from or at risk of suffering from a lung disease comprising administering to the subject a conjugate comprising a drug for lung treatment and a surface active agent by inhalation in an amount effective to induce a drug effect in the lungs.11-11-2010

Jack Guarnieri, Jackson, NJ US

Patent application numberDescriptionPublished
20110086687GAME MACHINE - A game machine comprises a housing, a user access panel having a controller, a money acceptor and a redemption dispenser that dispenses an award, a rotating field having a surface with a plurality of objects situated thereon, a retriever that is movable along a track that is supported by the housing for enabling movement of the retriever relative to the rotating field, an object return path having an object receiving area, a delivery guide, and an outlet, wherein an award is dispensed from the redemption dispenser upon the retriever retrieving an object from the rotating field and delivering it to the object receiving area.04-14-2011
20110115163GAME MACHINE - A game machine comprises a housing, a user access panel having a controller, a money acceptor, a rotating field having a surface for receiving a plurality of objects situated thereon, a retriever that is movable along a track that is supported by the housing for enabling movement of the retriever relative to the rotating field, an object receiving area, and an outlet for access to the object received within the object receiving area.05-19-2011

Michael Guarnieri, Baltimore, MD US

Patent application numberDescriptionPublished
20110287101RAPID RELEASE MINI-TABLETS PROVIDE ANALGESIA IN LABORATORY ANIMALS - Pellets containing an analgesic uniformly dispersed in a lipid carrier such as cholesterol mixed with fatty acid esters, can be used to provide long term pain relief. 5 mg cholesterol-tryglyceride-buprenorphine pellets released the majority of drug in 24-48 hours after implant and provide clinically significant plasma levels of analgesia in mice for 3-9 days. Blood levels of analgesia peak at day-1 and are substantially complete by day-5 depending on the level of buprenorphine. These results demonstrate that post surgical implants provide clinically significant levels of analgesia in the 24-48 hour period following surgery and thus obviate the time consuming, expensive, and high-risk need to inject mice post surgery. The pellets are safe and easy to use. Placed in the surgical wound at the end of surgery, they provide 2-3 days of analgesia and obviate the need for subsequent handling of the animal for pain therapy. The implants have no detectable effect on mouse behavior, hematology, or liver chemistry. The unexpected release kinetics of the 5 mg pellet provides an ideal implant for post surgical analgesia. These implants solve a significant problem facing scientists who use rodents in research and abide by international of animal welfare.11-24-2011

Ricardo Andre Guarnieri, Rio De Janeiro BR

Patent application numberDescriptionPublished
20110186515PROCESS FOR TREATMENT OF WATER/OIL EMULSIONS - A process for the treatment of water/oil (W/O) emulsions is described which includes the addition of an ionic liquid, under heating, to a water/oil emulsion containing between 0.5% and 85% of water per volume as a dispersion phase, until the concentration of the ionic liquid in the emulsion remains within the range of 0.01 μL/g to 100 μL/g. The ionic liquid used is a salt of a general C08-04-2011

Stuart Guarnieri, Laramie, WY US

Patent application numberDescriptionPublished
20100079815Systems and Methods for Luminance Determination - Systems and methods are provided for generating at least one look-up table, wherein the look-up table holds at least one luminance value in a second color space. In some embodiments, the luminance value can be computed for distinct combinations of color component values corresponding to a plurality of color components in a first color space. The method comprises computing at least one luminance value in the second color space based on a portion of the color component value combination; deriving an address in a look-up table based on the portion of the color component combination; and storing the computed luminance value in the look-up table at the derived address.04-01-2010
20100079817Method for optimizing the search for trapping regions - Methods disclosed permit the identification of frame buffer pixels for trapping. In some embodiments, flags associated with pixels in the frame buffer may be used to provide an indication of pixels for trapping. A first bit in a flag associated with a pixel may be set when the pixel is painted. In some embodiments, the method discloses a process for setting the value of a second bit in the flag to determine if the pixel associated with the flag lies on an object boundary. The pixel is identified as a candidate for trapping based on the value of the at least one flag.04-01-2010
20100149201Systems and Methods for Optimizing Pixel Based Raster Trapping - Methods disclosed permit the identification of frame buffer pixels for trapping. In some embodiments, flags associated with pixels in the frame buffer may be used to provide an indication of pixels for trapping. A bit in a flag associated with a pixel may be set when the pixel is painted, if the luminosity value of the pixel does not exceed a luminosity threshold. In some embodiments, the method discloses a process for updating the value of the bit through the rasterization process. The pixel may be identified as a candidate for trapping based on the value of the at least one bit at trapping time.06-17-2010
20100246948Systems and Methods for Enhancing Image Differences - Methods disclosed permit the enhancement of difference images associated with an image pair. In some embodiments, an enhanced difference image may be generated by selecting at least one non-zero target pixel in a thresholded difference image and performing operations on pixels that neighbor the target pixel in the thresholded difference image based on the value associated with the target pixel. In some embodiments, the operations on neighbors of the target pixel may be carried out using a user-specified paintbrush. The enhanced difference image may be rendered using a monitor or a printer.09-30-2010
20100246979Systems and Methods for Outlining Image Differences - Methods disclosed permit the outlining of difference images associated with an image pair. In some embodiments, an outlined difference image may be generated by selecting at least one non-zero pixel in a thresholded difference image and setting the value of the selected pixel to the maximum value permitted for that color space. In some embodiments, each color component of the selected pixel may be set to the maximum value permitted for that color component. The outlined difference image may also be scaled while preserving thresholded difference information. In some embodiments, the outlined difference image may be rendered using a monitor or a printer.09-30-2010

Tiziana Guarnieri, Bologna IT

Patent application numberDescriptionPublished
20100099730ANNELLATED PYRROLE COMPOUNDS FOR CANCER MANAGEMENT - The present invention relates to the use of annellated pyrrole compounds and in particular ML3000 (licofelone), salts or derivatives thereof, for cancer management, and in general to the use of a compound of Formula (I): wherein the variables have the meanings given in the present description, for the prevention and/or treatment of neoplasia, in particular neoplasia selected from the group consisting of papilloma, carcinoma, adenoma and adenocarcinoma, e.g. human airway or colorectal carcinoma, preferably fast-growing, multidrug resistant and/or COX-2 negative neoplasia. The invention further relates to pharmaceutical compositions for the aforesaid purposes, comprising annellated pyrrole compounds and in particular ML3000 (licofelone), optical isomers, salts or derivatives thereof, as well as to a method of treating and/or preventing neoplasia and/or restoring the ability to undergo apoptosis in a cell having lost the same. This treatment ameliorates, diminishes, actively treats, reverses or prevents any disease related to insufficient apoptosis, in particular neoplasia, and it may be combined with irradiation, heating and treatment with a cytotoxic agent for preventive and/or curative purposes.04-22-2010